Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Transplant Cell Ther. 2022 Mar 15;28(6):325.e1–325.e7. doi: 10.1016/j.jtct.2022.03.014

Figure 1:

Figure 1:

Overall Survival

Figure 1A: Original publication: The 3-year probability of overall survival after A: HLA-matched sibling (96%, 95% CI 93–97), B: Haploidentical relative (87%, 95% CI 76–93), C: HLA-matched unrelated (81%, 95% CI 73–88) and D: HLA-mismatched unrelated (82%, 95% CI 70–90) donor transplantation, adjusted for age and transplant conditioning regimen intensity.

Figure 1B: Reproduced from Public Data Source: The 5-year probability of overall survival after A: HLA-matched sibling (95%, 95% CI 93–97), B: Haploidentical relative (87%, 95% CI 79–93), C: HLA-matched unrelated (80%, 95% CI 71–86) and D: HLA-mismatched unrelated (82%, 95% CI 73–89) donor transplantation, adjusted for age and transplant conditioning regimen intensity.

HHS Vulnerability Disclosure